Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Emma Smith

Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
Showing 12 out of 73 results

In the final post in our series about the HOPON clinical trial, we hear from a patient who recently took part in the research, Gerard Dean. In the final post in our series about the HOPON clinical trial, we hear from a patient who recently took part in the research, Gerard Dean.

by Emma Smith | Analysis | 9 January 2015

9 January 2015

In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool. In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool.

by Emma Smith | Analysis | 8 January 2015

8 January 2015

In the first of a three-part series we hear from a doctor whose clinical trial was funded by Stand Up To Cancer in 2012. In the first of a three-part series we hear from a doctor whose clinical trial was funded by Stand Up To Cancer in 2012.

by Emma Smith | Analysis | 7 January 2015

7 January 2015

In the second part of this two-part series, we look at our work with industry, why it's important, and how we try to influence the way drugs get to patients. In the second part of this two-part series, we look at our work with industry, why it's important, and how we try to influence the way drugs get to patients.

by Emma Smith | Analysis | 17 December 2014

17 December 2014

This entry is part 2 of 2 in the series Dances with Pharma
Drugs

In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of reasons behind the spiralling costs. In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of reasons behind the spiralling costs.

by Emma Smith | Analysis | 16 December 2014

16 December 2014

This entry is part 1 of 2 in the series Dances with Pharma
An image of the human papillomavirus (HPV) vaccine

In the latest instalment of our cancer and infections series, we explore the history behind the cancer-causing human papillomavirus. In the latest instalment of our cancer and infections series, we explore the history behind the cancer-causing human papillomavirus.

by Emma Smith | Analysis | 16 September 2014

16 September 2014

This entry is part 5 of 5 in the series Cancer and Infections

A new arrival is an exciting time for any family. But rather than the patter of tiny feet, we’re welcoming the fully-grown footsteps of our latest additions. A new arrival is an exciting time for any family. But rather than the patter of tiny feet, we’re welcoming the fully-grown footsteps of our latest additions.

by Emma Smith | Analysis | 30 July 2014

30 July 2014

Concluding our story on Epstein-Barr virus and cancer, we explore the ongoing research into the virus and how this could lead to treatments in the future. Concluding our story on Epstein-Barr virus and cancer, we explore the ongoing research into the virus and how this could lead to treatments in the future.

by Emma Smith | Analysis | 9 April 2014

9 April 2014

This entry is part 4 of 5 in the series Cancer and Infections
  • Health & Medicine

50 years of Epstein-Barr virus

50 years ago three scientists published their findings on the first human virus that can cause cancer - read the story of Epstein-Barr virus. 50 years ago three scientists published their findings on the first human virus that can cause cancer - read the story of Epstein-Barr virus.

by Emma Smith | Analysis | 26 March 2014

26 March 2014

This entry is part 3 of 5 in the series Cancer and Infections
  • Science & Technology
  • Health & Medicine

Joining forces to fight lung cancer

What has the shape of a protein got to do with giving lung cancer patients the best treatments? A team of our researchers have the answer. What has the shape of a protein got to do with giving lung cancer patients the best treatments? A team of our researchers have the answer.

by Emma Smith | Analysis | 25 March 2014

25 March 2014

Helicobacter pylori

In the next in our Cancer and Infections series, we look at the stomach bug H. pylori and how it's linked with cancer. In the next in our Cancer and Infections series, we look at the stomach bug H. pylori and how it's linked with cancer.

by Emma Smith | Analysis | 7 March 2014

7 March 2014

This entry is part 2 of 5 in the series Cancer and Infections
  • Science & Technology
  • Health & Medicine

The link between cancer and infections

Can you catch cancer? The answer is no, but you can pick up an infection that increases the chances of developing certain types. Can you catch cancer? The answer is no, but you can pick up an infection that increases the chances of developing certain types.

by Emma Smith | Analysis | 26 February 2014

26 February 2014

This entry is part 1 of 5 in the series Cancer and Infections